Back to today’s briefing

Story perspectives

Recursion Cuts 160 Jobs to Ensure Financial Stability

6/11/2025

43 7

Summary

Story summary

Recursion, a Salt Lake City biopharma firm, is letting go of 20% of its workforce—about 160 employees—amidst financial hurdles and a need for a more efficient pipeline. This tough decision aims to bolster savings and extend their financial stability into late 2027, as they concentrate on developing treatments for cancer and rare diseases.

1 of 1

Story summary

Recursion, a Salt Lake City biopharma firm, is letting go of 20% of its workforce—about 160 employees—amidst financial hurdles and a need for a more efficient pipeline. This tough decision aims to bolster savings and extend their financial stability into late 2027, as they concentrate on developing treatments for cancer and rare diseases.